Condensed cyclic compound and organic light-emitting device including the same

US10396295B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10396295-B2
Application numberUS-201715466087-A
CountryUS
Kind codeB2
Filing dateMar 22, 2017
Priority dateSep 22, 2016
Publication dateAug 27, 2019
Grant dateAug 27, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A condensed cyclic compound represented by Formula 1: Ar 1 -(L 1 ) a1 -Ar 2   Formula 1 wherein, in Formula 1, a1, Ar 1 , Ar 2 , and L 1 are the same as described in the specification.

First claim

Opening claim text (preview).

What is claimed is: 1. A condensed cyclic compound represented by Formula 1: Ar 1 -(L 1 ) a1 -Ar 2   Formula 1 wherein, in Formulae 1, 2-3, and 3-1, Ar 1 is a group represented by Formula 2-3, Ar 2 is a group represented by Formula 3-1, L 1 is selected from a substituted or unsubstituted C 6 -C 60 arylene group, a substituted or unsubstituted C 1 -C 60 heteroarylene group, a substituted or unsubstituted divalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heteropolycyclic group, a1 is selected from 0, 1, 2, and 3, X 21 is selected from O, S, and Se, X 31 is selected from a single bond, O, S, N(R 33 ), C(R 33 )(R 34 ), Si(R 33 )(R 34 ), Ge(R 33 )(R 34 ), and P(═O)(R 33 ), A 21 , A 31 , and A 32 are each independently selected from a C 5 -C 30 carbocyclic group and a C 1 -C 30 heterocyclic group, R 21 to R 23 and R 31 to R 34 are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 7 -C 60 aryl alkyl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted C 2 -C 60 heteroaryl alkyl group, a substituted or unsubstituted C 1 -C 60 hetero aryloxy group, a substituted or unsubstituted C 1 -C 60 hetero arylthio group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —N(Q 1 )(Q 2 ), —Si(Q 1 )(Q 2 )(Q 3 ), and —B(Q 1 )(Q 2 ), R 22 and R 23 are optionally linked to form a substituted or unsubstituted C 5 -C 30 carbocyclic group or a substituted or unsubstituted C 1 -C 30 heterocyclic group, R 33 and R 34 are optionally linked via a first linking group to form a substituted or unsubstituted C 5 -C 30 carbocyclic group or a substituted or unsubstituted C 1 -C 30 heterocyclic group, b21, b31, and b32 are each independently selected from 1, 2, 3, 4, 5, 6, 7, and 8, Q 1 to Q 3 are each independently selected from: hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, and a C 1 -C 60 alkoxy group; a C 1 -C 60 alkyl group, substituted with at least one selected from deuterium, a C 1 -C 60 alkyl group, and a C 6 -C 60 aryl group; a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 7 -C 60 arylalkyl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a C 2 -C 60 heteroaryl alkyl group, a C 1 -C 60 hetero aryloxy group, a C 1 -C 60 hetero arylthio group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group; and a C 6 -C 60 aryl group, substituted with at least one selected from deuterium, a C 1 -C 60 alkyl group, and a C 6 -C 60 aryl group, and indicates a binding site to a neighboring atom. 2. The condensed cyclic compound of claim 1 , wherein L 1 is selected from: a phenylene group, a naphthylene group, a fluorenylene group, a phenanthrenylene group, an anthracenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a pyridinylene group, a pyrazinylene group, a pyrimidinylene group, and a triazinylene group; and a phenylene group, a naphthylene group, a fluorenylene group, a phenanthrenylene group, an anthracenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a pyridinylene group, a pyrazinylene group, a pyrimidinylene group, and a triazinylene group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a phenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, and a triazinyl group. 3. The condensed cyclic compound of claim 1 , wherein a1 is 0 or 1. 4. The condensed cyclic compound of claim 1 , wherein a1 iso. 5. The condensed cyclic compound of claim 1 , wherein A 21 is selected from a benzene group, a naphthalene group, a phenanthrene group, a pyrene group, a chrysene group, a triphenylene group, a fluoranthene group, an indene group, a fluorene group, a benzofluorene group, a dibenzofluorene group, a spiro-bifluorene group, a pyridine group, a pyrimidine group, a quinoline group, an isoquinoline group, an indole group, a carbazole group, a benzocarbazole group, a dibenzocarbazole group, a furan group, a benzofuran group, a dibenzofuran group, a naphtho furan group, a benzonaphtho furan group, a dinaphtho furan group, a thiophene group, a benzothiophene group, a dibenzothiophene group, a naphtho thiophene group, a benzonaphtho thiophene group, and a dinaphtho thiophene group. 6. The condensed cyclic compound of claim 1 , wherein A 21 is selected from a benzene group, a naphthalene group, a phenanthrene group, a pyrimidine group, a quinoline group, and an isoquinoline group. 7. The condensed cyclic compound of claim 1 , wherein Ar 1 is selected from groups represented by Formulae 2-11 to 2-14: wherein, in Formulae 2-11 to 2-14, X 21 , R 22 , and R 23 are the same as described in Formula 2-3, R 21a to R 21d are each independently the same as described in connection with R 21 in Formula 2-3, and indicates a binding site to a neighboring atom. 8. The condensed cyclic compound of claim 1 , wherein X 31 is selected from a single bond, O, S, N(R 33 ), and C(R 33 )(R 34 ). 9. The condensed cyclic compound of claim 1 , wherein A 31 and A 32 are each independently selected from a benzene group, a naphthalene group, a phenanthrene group, a pyrene group, a chrysene group, a triphenylene group, a fluoranthene group, an indene group, a fluorene group, a benzofluorene group, a dibenzofluorene group, a spiro-bifluorene grou

Assignees

Inventors

Classifications

  • containing organic luminescent materials · CPC title

  • Non-condensed systems · CPC title

  • with oxygen · CPC title

  • C07D519/00Primary

    Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 · CPC title

  • Electricity · mapped topic

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10396295B2 cover?
A condensed cyclic compound represented by Formula 1: Ar 1 -(L 1 ) a1 -Ar 2   Formula 1 wherein, in Formula 1, a1, Ar 1 , Ar 2 , and L 1 are the same as described in the specification.
Who is the assignee on this patent?
Samsung Electronics Co Ltd
What technology area does this patent fall under?
Primary CPC classification C07D519/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).